Literature DB >> 6987549

Progressive multifocal leukoencephalopathy (PML): in vitro cell-mediated immune responses to mitogens and JC virus.

E Willoughby, R W Price, B L Padgett, D L Walker, B Dupont.   

Abstract

Cell-mediated immunity was studied by in vitro tests in seven patients with progressive multifocal leukoencephalopathy (PML). Lymphocyte proliferation in response to mitogenic stimulation was reduced to a variable degree in all patients, indicating a general impairment of cell-mediated immune responsiveness, although mitogen-induced production of the lymphokine migration inhibitory factor (LIF) was normal in most cases. Cell-mediated immunity to JC virus (JCV) was assessed by LIF production in response to JCV antigen. In the six PML patients tested, LIF production with JCV antigen was absent despite the presence of antibody to JCV in serum. This contrasted with positive LIF production in seropositive normal individuals and patients and patients with other diseases. These results provide the first in vitro evidence of a depressed cell-mediated immune response to JCV in patients with PML, and support the hypothesis that PML is accompanied by a selective marked deficiency in cellular response to this virus in association with a general depression of cell-mediated immunity of variable severity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987549     DOI: 10.1212/wnl.30.3.256

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 2.  The immune response to infectious diseases of the central nervous system: a tenuous balance.

Authors:  A R Pachner
Journal:  Springer Semin Immunopathol       Date:  1996

3.  High incidence of JC viruria in JC-seropositive older individuals.

Authors:  Han Chang; Meilin Wang; Rong-Tai Tsai; Hui-Sheng Lin; Jin-Shue Huan; Wen-Chuang Wang; Deching Chang
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

4.  JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Authors:  I J Koralnik; R A Du Pasquier; N L Letvin
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 5.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

6.  Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

Authors:  Pankaj Seth; Frank Diaz; Eugene O Major
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 7.  Immune response in progressive multifocal leukoencephalopathy: an overview.

Authors:  T Weber; F Weber; H Petry; W Lüke
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

8.  Immunohistochemical detection of JC virus in nontumorous renal tissue of a patient with renal cancer but without progressive multifocal leukoencephalopathy.

Authors:  N Aoki; T Kitamura; T Tominaga; N Fukumori; Y Sakamoto; K Kato; M Mori
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

9.  [Progressive multifocal leukoencephalopathy in Wegener's granulomatosis in relation to therapy with cyclosporin A].

Authors:  J Ettinger; W Feiden; G Hübner; M Schreiner
Journal:  Klin Wochenschr       Date:  1989-02-15

Review 10.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.